BCTXZ
BriaCell Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · CA
$0.11
+3.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.01x
- Price / sales
- -4.09x
- Price / cash flow
- -0.00x
Enterprise value
- Enterprise value
- -$21.2M
- EV / sales
- 401.03x
- EV / EBITDA
- 0.27x
- EV / EBIT
- 0.65x
- Market cap
- $215.9K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026